Chronic Pain Clinical Trial
Official title:
Effect of Egoscue Corrective Exercise Prescription on Acute and Short-term Chronic Knee and Hip Pain
The primary purpose of this experimental study was to determine the acute effect following one treatment and the short-term effect after a two-week program of Egoscue corrective exercises on chronic knee and hip pain.
Participants for this study were recruited from the university community via email
announcements and flyers. Participants were adults with chronic knee and/or hip pain.
Chronic pain was defined as pain on most days of the week for at least 12 weeks. Individuals
were excluded from the study if they (a) had undergone a knee or hip surgery or had
sustained a knee or hip injury in the past 12 months, (b) were currently receiving any form
of pain treatment such as physiotherapy, chiropractic, intraarticular injections, or
prescription pain medications, (c) exhibited a severe lack of mobility, (d) reported an
initial pain level < 3 cm on the Visual Analog Scale (VAS) scale, (e) were pregnant, or (f)
were unable to understand English. Individuals were not excluded from participation if they
were taking non-prescription drugs such as nonsteroidal anti-inflammatory drugs, although
they were required to refrain from taking any pain medication during the 12 hours preceding
the first, and subsequent assessments. A power analysis using a power level of 80% and alpha
set at 0.05 indicated a sample size of 40 participants (20 in the control group and 20 in
the exercise group). A large effect size (0.80) was assumed because this has been reported
in the literature26 for differences in Western Ontario and McMaster Universities Arthritis
Index (WOMAC) scores following an at-home exercise program. Forty-two eligible participants
were originally recruited.
All participants completed a pre-participation questionnaire that included questions about
age, gender, injuries, pain medication use, and previous or planned total hip and/or knee
arthroplasty. Participants completed two versions of the VAS for knee and/or hip pain: one
for pain at rest and one for pain during movement. If participants had pain in multiple
joints, they were told to record their overall level of pain. Participants were told to
indicate their "usual pain" over the past seven days. Participants needed to have a VAS pain
score of at least 3 cm (either at rest or during movement) in order to participate in the
study. Participants also completed the WOMAC at the time of the visit. Participants' body
mass was measured to the nearest 0.1 kg and height to the nearest 0.5 cm using a digital
scale and a stadiometer, respectively.
Egoscue Method protocol was followed and a postural alignment specialist trained in postural
evaluation conducted an assessment. To reduce possible inter-rater error, the same
researcher conducted all postural evaluations. An individualized exercise program (E-cise
menu) was generated using the ePeteTM software (version 4.4.3) based on the noted postural
deviations. To ensure that all participants were prescribed the same volume of exercise, the
E-cise menus were adjusted by adding or removing exercises so the time required to complete
the exercises was approximately 45 minutes.
Participants in the exercise group were led through their complete E-cise menu by the
researcher to ensure competency on the exercises. Participants in the control group did not
perform any exercises for 45 minutes. Following the first exercise session or 45 minutes of
rest, participants completed the VAS again for their current knee and/or hip pain at rest
and with movement.
All participants were given logs (one for each day of the week), which they were to fill out
every evening before retiring to bed. These logs contained questions about their compliance
to the E-cise menu (for those in the exercise group), pain medication use, and a VAS for
pain at rest and during movement. Participants in the control group were instructed to
maintain their current lifestyle for the two week duration of the study and a return visit
was scheduled one week later. Participants in the exercise group were scheduled for a return
visit the following day so that E-cises could be observed for competency and any adjustments
could be made to the E-cise menu if participants were experiencing pain during an E-cise.
Participants in the exercise group were instructed to complete their E-cise menu at home on
at least five days of the week, but preferably every day, for the next two weeks.
All participants were assessed and evaluated on all variables previously mentioned at the
end of week number 1 and again at the end of the study after week number 2. Participants in
the control group were given a personalized E-cise menu, along with instructions, at this
time.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|